Education
About Us
Working with TipRanks
Follow Us
Teladoc (TDOC)
NYSE:TDOC
TDOC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.35 - $15.21
Previous CloseN/A
Volume1.13M
Average Volume (3M)5.27M
Market Cap
$1.26B
Enterprise Value$1.86B
Total Cash (Recent Filing)$46.44M
Total Debt (Recent Filing)$26.03M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Jul 29, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.88
Shares Outstanding175,277,830
10 Day Avg. Volume4,831,549
30 Day Avg. Volume5,272,134
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.47
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.02
Enterprise Value/Ebitda-3.16
Forecast
1Y Price Target
$9.59Price Target Upside37.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
---
Bulls Say, Bears Say
Bulls Say
AcquisitionsThe acquisition of UpLift provides a solid pathway for in-network coverage option in the BetterHelp segment, potentially stemming further deterioration by offering affordability in an uncertain economic climate.
Financial PerformanceConsolidated revenue and adj-EBITDA both beat analyst and consensus estimates, indicating strong financial performance.
Strategic PartnershipsTeladoc recently announced new initiatives including an integration with Eli Lilly, partnership with Amazon, and acquisition of Catapult Health.
Bears Say
BetterHelp Segment PerformanceBetterHelp sales fell 11% from the prior-year period with adjusted EBITDA down 50% year-over-year.
Consumer DemandMacro trends and weaker consumer confidence may pressure consumer demand and make it difficult to reaccelerate the business.
Revenue GrowthAverage revenue per US Integrated Care Member fell 8.6% sequentially and 8.0% year-over-year, which could impact overall revenue growth.
---
Ownership Overview
0.56% Insiders
17.10% Mutual Funds
0.01% Other Institutional Investors
65.09% Public Companies and
Individual Investors
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $6.35 and its highest was $15.21 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $1.26B.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Jul 29, 2025 which is in 88 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Apr 30, 2025. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.343 by -$0.187.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.24.
How many shares outstanding does Teladoc have?
Teladoc has 175,277,830 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.343. Following the earnings report the stock price went down -2.782%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in TDOC
---
Teladoc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.59 (37.20% Upside)
$9.59 (37.20% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 78%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.60%
12-Months-Change
Fundamentals
Return on Equity
-52.46%
Trailing 12-Months
Asset Growth
-19.98%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
---
TDOC Company Deck
---
TDOC Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive strategic developments such as the acquisition of UpLift, growth in the Integrated Care segment, and international success, but these were offset by financial challenges, including revenue decline, net losses, and macroeconomic concerns. The sentiment is balanced, reflecting both opportunities and challenges.Read More>---
TDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
---
TDOC Stock 12 Month Forecast
Average Price Target
$9.59
▲(37.20% Upside)
Technical Analysis
National Healthcare
―
Phreesia
―
Arcutis Biotherapeutics
―
Schrodinger
―
Enliven Therapeutics
―
---